Identification of Genetic Alterations in Periodontitis Patients with Poorly Controlled Type 2 Diabetes Mellitus

Year 2022, Volume: 49 Issue: 3, 101 - 107, 31.12.2022

Duru Aras Tosun , Aynur Karadağ

https://doi.org/10.52037/eads.2022.0041

Abstract

Purpose Periodontitis and diabetes are highly prevalent chronic diseases associated with upregulated inflammation that may adversely affect each other. The aim of this study is to determine underlying molecular mechanisms via bioinformatic tools as a guide for future studies.
Materials and methods
Expression data (GSE156993) of Type 2 Diabetes Mellitus (T2DM) and Periodontitis (P) patients was selected from the Gene Expression Omnibus (GEO) database. Study groups were defined as follows; T2DM-poor (HbA1c≥8.5%, n=7), T2DM-well (HbA1c<7.0%, n=7) and P (n=6). The differentially expressed genes (DEGs) between groups were analyzed with GEO2R (log2FC≥0 or ≤0). Kyoto Encyclopedia of Genes and Genomes (KEGG) was used for the identification of biological pathways. Protein network was constructed in STRING database and hub genes were detected. Data validation was performed via ELISA assay for two hub genes. Significance was set to P<0.05.
Results
1008 genes were upregulated, while 610 genes were down-regulated in T2DM-poor group compared to the controls. KEGG analysis revealed that the highest number of down-regulated genes were clustered in cancer pathways and PI3K-Akt signaling pathway, as upregulated genes were purine metabolism, parathyroid hormone metabolism, cGMP-PKG signaling pathway and Rap1 signaling pathway. For increasing and decreasing expression profiles, hub nodes with the highest score were selected as SMAD4, HNF4A, SMARCA4 and SRC, TNF, RFC2, RFC3 genes, respectively.
Conclusion Bioinformatic analyses revealed that metabolomic, inflammatory and cancer pathways were altered in periodontitis patients with poorly controlled diabetes. As protein-protein interactions may differ in vivo, further validation of the presented data is needed.

Keywords

Type 2 Diabetes Mellitus, Periodontitis, Bioinformatic Analysis, GEO, Microarray

References

• 1. Mealey B. Diabetes and periodontal disease: two sides of a coin. Compendium of continuing education in dentistry (Jamesburg, NJ: 1995). 2000;21(11):943-6, 8, 50, passim; quiz 56.
• 2. Preshaw PM, Bissett SM. Periodontitis and diabetes. British dental journal. 2019;227(7):577-84.
• 3. Organization WH. Classification of diabetes mellitus. 2019.
• 4. Serrano-Ríos M, Corbatón A. Diabetes mellitus, heart failure and mortality. Medicina Clínica. 2005;125(5):182-3.
• 5. Soskolne WA. Epidemiological and clinical aspects of periodontal diseases in diabetics. Annals of periodontology. 1998;3(1):3-12.
• 6. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. The lancet. 2005;366(9499):1809-20.
• 7. Bascones Martínez A, Matesanz Perez P, Escribano-Bermejo M, González Moles M-A, Bascones Ilundain J, Meurman JH. Periodontal disease and diabetes: review of the literature. 2011.
• 8. Lalla E, Cheng B, Lal S, Kaplan S, Softness B, Greenberg E, et al. Diabetes mellitus promotes periodontal destruction in children. Journal of clinical periodontology. 2007;34(4):294-8.
• 9. Polak D, Shapira L. An update on the evidence for pathogenic mechanisms that may link periodontitis and diabetes. Journal of clinical periodontology. 2018;45(2):150-66.
• 10. Taylor JJ, Preshaw PM, Lalla E. A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. Journal of clinical periodontology. 2013;40:S113-S34.
• 11. Covani U, Marconcini S, Giacomelli L, Sivozhelevov V, Barone A, Nicolini C. Bioinformatic prediction of leader genes in human periodontitis. Journal of periodontology. 2008;79(10):1974-83.
• 12. Guo X, Wang Y, Wang C, Chen J. Identification of several hub-genes associated with periodontitis using integrated microarray analysis. Molecular Medicine Reports. 2015;11(4):2541-7.
• 13. Jia Z, Wang Y, Xu Y, Cui T, Wei Y, Wang P, et al. Aberrant gene expression profiles and related pathways in chronic periodontitis. International Journal of Clinical & Experimental Medicine. 2016;9(11).
• 14. Kang J, Kwon EJ, Ha M, Lee H, Yu Y, Kang JW, et al. Identification of Shared Genes and Pathways in Periodontitis and Type 2 Diabetes by Bioinformatics Analysis. Frontiers in endocrinology. 2021;12.
• 15. Corbi SC, de Vasconcellos JF, Bastos AS, Bussaneli DG, da Silva BR, Santos RA, et al. Circulating lymphocytes and monocytes transcriptomic analysis of patients with type 2 diabetes mellitus, dyslipidemia and periodontitis. Scientific reports. 2020;10(1):1-14.
• 16. Aras-Tosun D, Önder C, Akdoğan N, Kurgan Ş, Aktay İ, Tuncay E, et al. Astaxanthin Enhances Gingival Wound Healing following High Glucose-Induced Oxidative Stress. BioMed Research International.2022.
• 17. Mealey BL, Oates TW. Diabetes mellitus and periodontal diseases. Journal of periodontology. 2006;77(8):1289-303.
• 18. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community dentistry and oral epidemiology. 2002;30(3):182-92.
• 19. Barnes VM, Kennedy AD, Panagakos F, Devizio W, Trivedi HM, Jönsson T, et al. Global metabolomic analysis of human saliva and plasma from healthy and diabetic subjects, with and without periodontal disease. PloS one. 2014;9(8):e105181.
• 20. Chen Z-y, Ye L-w, Zhao L, Liang Z-j, Yu T, Gao J. Hyperuricemia as a potential plausible risk factor for periodontitis. Medical Hypotheses. 2020;137:109591.
• 21. Narendra S, Das UK, Tripathy SK, Sahani NC. Superoxide Dismutase, Uric Acid, Total Antioxidant Status, and Lipid Peroxidation Assay in Chronic and Aggressive Periodontitis Patients. The Journal of Contemporary Dental Practice. 2018;19(7):874-80.
• 22. Barros S, Silva M, Somerman M, Nociti Jr F. Parathyroid hormone protects against periodontitis-associated bone loss. Journal of dental research. 2003;82(10):791-5.
• 23. Tokunaga K, Seto H, Ohba H, Mihara C, Hama H, Horibe M, et al. Topical and intermittent application of parathyroid hormone recovers alveolar bone loss in rat experimental periodontitis. Journal of periodontal research. 2011;46(6):655-62.
• 24. Loureiro C, Buzalaf MAR, Moraes F, Ventura TMO, Pelá VT, Pessan JP, et al. Quantitative proteomic analysis in symptomatic and asymptomatic apical periodontitis. International Endodontic Journal. 2021;54(6):834-47.
• 25. Nath SG, Raveendran R. An insight into the possibilities of fibroblast growth factor in periodontal regeneration. Journal of Indian Society of Periodontology. 2014;18(3):289.
• 26. Ekuni D, Firth J, Putnins E. Regulation of epithelial cell growth factor receptor protein and gene expression using a rat periodontitis model. Journal of periodontal research. 2006;41(4):340-9.
• 27. Zhao Z, Wang H, Li X, Hou J, Yang Y, Li H. Comprehensive analysis of DNA methylation for periodontitis. International Journal of Implant Dentistry. 2022;8(1):1-11.
• 28. Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Annals of medicine. 2014;46(6):372-83.
• 29. Hoare A, Soto C, Rojas-Celis V, Bravo D. Chronic inflammation as a link between periodontitis and carcinogenesis. Mediators of inflammation. 2019;2019.
• 30. Xiong Y, Zhao B, Zhang W, Jia L, Zhang Y, Xu X. Curcumin promotes osteogenic differentiation of periodontal ligament stem cells through the PI3K/AKT/Nrf2 signaling pathway. Iranian Journal of Basic Medical Sciences. 2020;23(7):954.
• 31. Zhao B, Xiong Y, Zhang Y, Jia L, Zhang W, Xu X. Rutin promotes osteogenic differentiation of periodontal ligament stem cells through the GPR30-mediated PI3K/AKT/mTOR signaling pathway. Experimental Biology and Medicine. 2020;245(6):552-61.
• 32. Shimabukuro Y, Terashima H, Takedachi M, Maeda K, Nakamura T, Sawada K, et al. Fibroblast growth factor‐2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction. Journal of cellular physiology. 2011;226(3):809-21.
• 33. Liu F, Huang X, He J-j, Song C, Peng L, Chen T, et al. Plantamajoside attenuates inflammatory response in LPS-stimulated human gingival fibroblasts by inhibiting PI3K/AKT signaling pathway. Microbial pathogenesis. 2019;127:208-11.
• 34. Li L, Sun W, Wu T, Lu R, Shi B. Caffeic acid phenethyl ester attenuates lipopolysaccharide-stimulated proinflammatory responses in human gingival fibroblasts via NF-κB and PI3K/Akt signaling pathway. European Journal of Pharmacology. 2017;794:61-8.
• 35. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y. Periodontal disease and diabetes mellitus: the role of tumor necrosis factor‐α in a 2‐way relationship. Journal of periodontology. 2003;74(1):97-102.
• 36. Kaarthikeyan G, Balakrishnan A, Jayakumar ND. The link between the genetic polymorphisms of the innate immune signaling molecular factors with periodontitis. Journal of Biological Research-Bollettino della Società Italiana di Biologia Sperimentale. 2018;91(1).
• 37. Miskiewicz A, Szparecki G, Durlik M, Rydzewska G, Ziobrowski I, Górska R. The Q705K and F359L single-nucleotide polymorphisms of NOD-like receptor signaling pathway: association with chronic pancreatitis, pancreatic cancer, and periodontitis. Archivum immunologiae et therapiae experimentalis. 2015;63(6):485-94.
• 38. Leite FR, Enevold C, Bendtzen K, Baelum V, López R. Pattern recognition receptor polymorphisms in early periodontitis. Journal of periodontology. 2019;90(6):647-54.